P21 Effect of insulin degludec vs insulin glargine in a one-year randomized trial in insulin-naïve patients with type 2 diabetes

Primary Care Diabetes ◽

10.1016/j.pcd.2012.10.064 ◽

2013 ◽

Vol 7 (1) ◽

pp. 81

Author(s):

A. Rana ◽

B. Zinman ◽

A. Philis-Tsimikas ◽

Y. Handelsman ◽

H.W. Rodbard ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Randomized Trial ◽

Insulin Degludec ◽

Download Full-text

Decision letter for "A greater proportion of participants with type 2 diabetes achieve treatment targets with IDegLira (insulin degludec/liraglutide) versus insulin glargine U100 at 26 weeks: DUAL VIII a randomized trial designed to resemble clinical practice"

10.1111/dom.13957/v2/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Clinical Practice ◽

Insulin Glargine ◽

Randomized Trial ◽

Insulin Degludec ◽

Treatment Targets

Download Full-text

A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks: DUAL VIII, a randomized trial designed to resemble clinical practice

Diabetes Obesity and Metabolism ◽

10.1111/dom.13957 ◽

2020 ◽

Vol 22 (5) ◽

pp. 873-878 ◽

Author(s):

Giorgio Sesti ◽

Lars Bardtrum ◽

Selcuk Dagdelen ◽

Natalie Halladin ◽

Martin Haluzík ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Practice ◽

Insulin Glargine ◽

Randomized Trial ◽

Insulin Degludec ◽

Treatment Targets

Download Full-text

Decision letter for "A greater proportion of participants with type 2 diabetes achieve treatment targets with IDegLira (insulin degludec/liraglutide) versus insulin glargine U100 at 26 weeks: DUAL VIII a randomized trial designed to resemble clinical practice"

10.1111/dom.13957/v1/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Clinical Practice ◽

Insulin Glargine ◽

Randomized Trial ◽

Insulin Degludec ◽

Treatment Targets

Download Full-text

The Effect of Insulin Degludec on Glycemic Control and Nocturnal Hypoglycemia Compared with Insulin Glargine: a 1-year Randomized Trial in Insulin-naïve People with Type 2 Diabetes

Canadian Journal of Diabetes ◽

10.1016/j.jcjd.2012.07.402 ◽

2012 ◽

Vol 36 (5) ◽

pp. S58

Author(s):

Bernard Zinman ◽

Athena Philis-Tsimikas ◽

Yehuda Handelsman ◽

Helena W. Rodbard ◽

Bertrand Cariou ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Insulin Glargine ◽

Randomized Trial ◽

Insulin Degludec ◽

Nocturnal Hypoglycemia

Download Full-text

Review for "A greater proportion of participants with type 2 diabetes achieve treatment targets with IDegLira (insulin degludec/liraglutide) versus insulin glargine U100 at 26 weeks: DUAL VIII a randomized trial designed to resemble clinical practice"

10.1111/dom.13957/v1/review2 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Clinical Practice ◽

Insulin Glargine ◽

Randomized Trial ◽

Insulin Degludec ◽

Treatment Targets

Download Full-text

One‐year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal‐time insulin: the EDITION 1 12‐month randomized trial, including 6‐month extension

Diabetes Obesity and Metabolism ◽

10.1111/dom.12472 ◽

2015 ◽

Vol 17 (9) ◽

pp. 835-842 ◽

Author(s):

M. C. Riddle ◽

H. Yki‐Järvinen ◽

G. B. Bolli ◽

M. Ziemen ◽

I. Muehlen‐Bartmer ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Insulin Glargine ◽

Randomized Trial ◽

Meal Time ◽

Download Full-text

Review for "A greater proportion of participants with type 2 diabetes achieve treatment targets with IDegLira (insulin degludec/liraglutide) versus insulin glargine U100 at 26 weeks: DUAL VIII a randomized trial designed to resemble clinical practice"

10.1111/dom.13957/v2/review1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Clinical Practice ◽

Insulin Glargine ◽

Randomized Trial ◽

Insulin Degludec ◽

Treatment Targets

Download Full-text

Author response for "A greater proportion of participants with type 2 diabetes achieve treatment targets with IDegLira (insulin degludec/liraglutide) versus insulin glargine U100 at 26 weeks: DUAL VIII a randomized trial designed to resemble clinical practice"

10.1111/dom.13957/v2/response1 ◽

2019 ◽

Author(s):

Giorgio Sesti ◽

Lars Bardtrum ◽

Selcuk Dagdelen ◽

Natalie Halladin ◽

Martin Haluzík ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Practice ◽

Insulin Glargine ◽

Randomized Trial ◽

Insulin Degludec ◽

Author Response ◽

Treatment Targets

Download Full-text

Review for "A greater proportion of participants with type 2 diabetes achieve treatment targets with IDegLira (insulin degludec/liraglutide) versus insulin glargine U100 at 26 weeks: DUAL VIII a randomized trial designed to resemble clinical practice"

10.1111/dom.13957/v1/review1 ◽

2019 ◽

Author(s):

Subhankar Chowdhury

Keyword(s):

Type 2 Diabetes ◽

Clinical Practice ◽

Insulin Glargine ◽

Randomized Trial ◽

Insulin Degludec ◽

Treatment Targets

Download Full-text

Exenatide Versus Insulin Glargine in Patients With Suboptimally Controlled Type 2 Diabetes: A Randomized Trial

Yearbook of Endocrinology ◽

10.1016/s0084-3741(08)70285-3 ◽

2006 ◽

Vol 2006 ◽

pp. 56-61

Author(s):

J.L. Leahy ◽

L. Kennedy

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Randomized Trial

Download Full-text